NanoVibronix

NanoVibronix develops medical devices based on a proprietary therapeutic ultrasound technology. Its products address a range of clinical applications including catheter-related injuries and their complications, pain, and soft tissue healing. The company's patented technology allows for the creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. The technology can be utilized for a variety of medical applications requiring low-cost ultrasound therapy. The NanoVibronix PainShield device is a wearable, battery-powered electronic unit that uses a disposable patch through which it delivers localized energy, creating a therapeutic effect to relieve localized pain and induce soft tissue healing. PainShield has gained CE Mark certification and also carries FDA clearance. The UroShield system is a multi-targeted solution intended to work with a number of factors essential to preventing catheter-related complications. The device is CE mark certified. The company's WoundShield, designed to accelerate wound healing, may also be used to enhance oxygen and topical drug delivery.

NanoVibronix has raised $24.5M in total funding across 9 rounds. The company is currently at the Public stage. Key investors include Undisclosed Investor(s).

NanoVibronix operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Sensing, Acoustics, Simulation & Imaging, Ultrasound. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients.

NanoVibronix is based in Derech HaShalom 9, Nesher, Israel, North District. The company also has offices abroad.